View Cart (0 items)

Pharmaceutical

Daiichi says open offer for Ranbaxy opens soon

June 16, 2008
According to Reuters, Japanese drug maker Daiichi Sankyo said recently its open offer to buy up to 20 percent in India''s Ranbaxy Laboratories would open soon.Daiichi struck a deal last
Read More

Elan said mulling separate listing for EDT unit

June 12, 2008
According to Reuters, Irish drugmaker Elan is likely to separately list its development and manufacturing division Elan Drug Technology (EDT), worth up to $1.5 billion (757 million pounds), if it
Read More

Cadila Healthcare to buy S Africa''s Simayla

June 9, 2008
Reuters is reporting that Indian drugmaker Cadila Healthcare Ltd. said recently it has acquired 70 percent in South Africa''s Simayla Pharmaceuticals, marking the Indian firm''s second buy in less than
Read More

EU urges more collaboration after Heparin scandal

June 9, 2008
According to Reuters, Western drug agencies need to step up cooperation to head off a repeat of the recent scandal over tainted Heparin and protect patients from counterfeits, Thomas
Read More

Mylan, Abbott settle anti-seizure drug dispute

June 6, 2008
According to the Associated Press, generic drug developer Mylan Inc. said recently that a subsidiary has entered into a settlement and license agreement with Abbott Laboratories relating to a generic
Read More

Novartis buys antibiotics maker Protez

June 4, 2008
According to the Associated Press, Swiss pharmaceuticals company Novartis AG said recently it is buying U.S.-based antibiotics developer Protez Pharmaceuticals Inc. for as much as $400 million.Protez, based in Malvern,
Read More

Mylan acquires eastern European Merck KGaA units

June 2, 2008
The Associated Press is reporting that generic and specialty pharmaceutical company Mylan Inc. said recently it has acquired the central eastern European generics businesses of German drug maker Merck KGaA,
Read More

Bristol-Myers to buy Kosan for $5.50 per share

May 30, 2008
According to the Associated Press, drug developer Bristol-Myers Squibb Co. said recently it will pay $5.50 per share in cash for cancer therapy maker Kosan Biosciences Inc., in a move
Read More

FAA Bans Chantix for Pilots, Air Traffic Controllers

May 27, 2008
According to the Wall Street Journal, Pfizer’s smoking-cessation drug Chantix came in for a bit more trouble recently as a research group cited reports of physical side effects associated with
Read More

Ga. family challenges federal vaccine law

May 21, 2008
The Associated Press is reporting that Stefan Ferrari''s parents say he was a talkative toddler until he got a round of booster shots with a mercury preservative. Now age 10,
Read More